share_log

河南太龙药业股份有限公司收购北京新领先医药科技发展有限公司形成的商誉减值测试项目资产评估报告

Asset evaluation report for the goodwill impairment test project formed by Henan Tailong Pharmaceutical Co., Ltd.'s acquisition of Beijing New Leading Pharmaceutical Technology Development Co., Ltd.

深证信a股 ·  Mar 27
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more